MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock and...
$75,172K
Proceeds from employee
stock purchase plan
$326K
Maturities of short term
treasury securities
-$145,000K
Proceeds from exercise of
stock options
$1K
Net cash provided by
financing activities
$75,245K
Net cash provided by
(used in) investing...
$2,393K
Canceled cashflow
$254K
Canceled cashflow
$142,607K
Net change in cash,
cash equivalents and...
-$17,608K
Canceled cashflow
$77,638K
Stock-based compensation
expense
$14,267K
Depreciation and
amortization expense
$6,381K
Noncash lease expense
$3,383K
Accrued and other
current and non-current...
$1,904K
Prepaid expenses and
other current assets
-$1,681K
Accounts payable
$1,029K
Other non-current
assets
-$308K
Loss on disposal of
property and equipment
-$103K
Amortization of deferred
transaction costs
$43K
Principal payments on
finance leases
$150K
Taxes withheld and
paid related to net...
-$104K
Purchases of short-term
treasury securities
$140,869K
Purchase of property and
equipment
$1,738K
Net cash used in
operating activities
-$95,246K
Canceled cashflow
$29,099K
Net loss
-$116,803K
Net amortization of
premiums and accretion...
$4,093K
Operating lease liability
-$3,449K
Back
Back
Cash Flow
source: myfinsight.com
Adicet Bio, Inc. (ACET)
Adicet Bio, Inc. (ACET)